Published in J Natl Cancer Inst on July 07, 1999
Hepatocellular carcinoma--cause, treatment and metastasis. World J Gastroenterol (2001) 3.95
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut (2003) 3.91
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Biol (2001) 2.69
The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol (2002) 2.47
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut (2000) 1.89
p73 in Cancer. Genes Cancer (2011) 1.33
Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride. Br J Cancer (2001) 1.18
Identification of two contiguous minimally deleted regions on chromosome 1p36.31-p36.32 in oligodendroglial tumours. Br J Cancer (2004) 1.11
p73 poses a barrier to malignant transformation by limiting anchorage-independent growth. EMBO J (2008) 1.01
p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival. World J Gastroenterol (2010) 0.87
Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score. J Clin Pathol (2005) 0.86
p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer (2001) 0.84
Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73. BMC Cancer (2010) 0.84
p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. J Mol Histol (2007) 0.83
The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma. Yale J Biol Med (2003) 0.83
N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy. Oncogene (2012) 0.83
p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma. Dig Dis Sci (2002) 0.79
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol (2015) 0.79
Preclinical activity of combined HDAC and KDM1A inhibition in glioblastoma. Neuro Oncol (2015) 0.79
Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma. World J Gastroenterol (2005) 0.78
The p53R172H mutant does not enhance hepatocellular carcinoma development and progression. PLoS One (2015) 0.77
Assessment of the Proliferative Marker Ki-67 and p53 Protein Expression in HBV- and HCV-related Hepatocellular Carcinoma Cases in Egypt. Int J Health Sci (Qassim) (2008) 0.76
Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines. J Mol Histol (2010) 0.76
Disruption of chromosomal locus 1p36 differentially modulates TAp73 and ΔNp73 expression in follicular lymphoma. Leuk Lymphoma (2014) 0.75
International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer (1999) 4.16
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut (2003) 3.91
Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg (1991) 3.12
The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71
Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J (1995) 2.67
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
[A 32-year-old patient with diarrhoea and acute kidney failure]. Internist (Berl) (2006) 2.02
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation]. Langenbecks Arch Chir (1988) 2.02
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. Hepatology (2000) 2.02
Human allograft acceptance is associated with immune regulation. J Clin Invest (2000) 1.94
Cell cycle regulation of E2F site occupation in vivo. Science (1996) 1.90
Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut (2000) 1.89
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J Biol Chem (2000) 1.64
The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res (2007) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke (1998) 1.62
Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br J Surg (1990) 1.60
Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer (2000) 1.56
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases. Gut (1987) 1.54
Residual tumor (R) classification and prognosis. Semin Surg Oncol (1994) 1.51
Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging (2002) 1.50
Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples. J Med Genet (2005) 1.49
Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer (1998) 1.49
The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated. Oncogene (1999) 1.47
A 30-s PAS stain for frozen sections. Am J Surg Pathol (1992) 1.46
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Anatomic changes in multiple brainstem nuclei after incremental, near-complete neurotoxic destruction of the pre-Bötzinger Complex in adult goats. Respir Physiol Neurobiol (2010) 1.44
Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology (2000) 1.43
[The current TNM system for gastrointestinal tumors part II]. Pathologe (2010) 1.43
[Auto-CPAP treatment in obstructive sleep apnea syndrome: a prospective randomized study during initiation of treatment]. Dtsch Med Wochenschr (1997) 1.43
[Continuous intraoperative neuromonitoring of the recurrent laryngeal nerve in thyroid surgery (CIONM) - Where are we now? An update to the European Symposium of Continuous Neuromonitoring in Thyroid Surgery]. Zentralbl Chir (2011) 1.41
[Chronic pancreatitis]. Dtsch Med Wochenschr (2008) 1.41
[Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder]. Z Gastroenterol (2005) 1.40
[Indications for liver biopsy in liver tumors]. Dtsch Med Wochenschr (2000) 1.38
Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc (1999) 1.37
Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol (1996) 1.37
The tumour suppressor protein p53 can repress transcription of cyclin B. Nucleic Acids Res (2000) 1.36
[Evaluation of the clinical utility of autopsy: an investigation at the Institute of Pathology, University Hospital of Leipzig]. Pathologe (2008) 1.35
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol (2001) 1.33
Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res (1995) 1.31
Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J (1998) 1.30
Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology (2000) 1.30
Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis (2003) 1.30
Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol (2011) 1.28
Helicobacter pylori infection: a risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med (2000) 1.27
Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res (1996) 1.25
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene (2001) 1.23
Risk of invasive carcinoma in colorectal adenomas assessed by size and site. Int J Colorectal Dis (1997) 1.21
Carotid body denervation alters ventilatory responses to ibotenic acid injections or focal acidosis in the medullary raphe. J Appl Physiol (1985) (2004) 1.21
The pathologist and the residual tumor (R) classification. Pathol Res Pract (1994) 1.20
Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med (2001) 1.18
[Subjective refraction assessment. II: Monocular fine adjustment]. Ophthalmologe (2002) 1.18
Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride. Br J Cancer (2001) 1.18
Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet (1992) 1.17
Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat (1998) 1.17
Long-term experience after ex situ liver surgery. Surgery (2000) 1.16
Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys (1998) 1.16
Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart (2003) 1.14
Invasive carcinoma in colorectal adenomas: multivariate analysis of patient and adenoma characteristics. Endoscopy (1997) 1.14
Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. Eur J Surg Oncol (2007) 1.14
[Determining subjective refraction. III: Binocular balance, near vision eyeglasses]. Ophthalmologe (2002) 1.12
Impact of maternal body mass index on neonatal outcome. Eur J Med Res (2009) 1.12
The glyoxysomal beta-oxidation system in cucumber seedlings: identification of enzymes required for the degradation of unsaturated fatty acids. Arch Biochem Biophys (1988) 1.11
Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer (2009) 1.11
Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract (2008) 1.11
Prospective multicenter study of the quality of oncologic resections in patients undergoing laparoscopic colorectal surgery for cancer. The Laparoscopic Colorectal Surgery Study Group. Dis Colon Rectum (1998) 1.10
Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer (2012) 1.10
Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients. Br J Cancer (2011) 1.09
Doppler assessment of the uterine circulation in the second trimester in twin pregnancies: prediction of pre-eclampsia, fetal growth restriction and birth weight discordance. Ultrasound Obstet Gynecol (2002) 1.08
Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol (2001) 1.08
Anthranoid laxative use is not a risk factor for colorectal neoplasia: results of a prospective case control study. Gut (2000) 1.08
The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol (1985) 1.07
Esophageal intramural pseudodiverticulosis: endoscopic diagnosis and therapy. Dis Esophagus (2013) 1.07
Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer (2000) 1.07
[2010 TNM system: on the 7th edition of TNM classification of malignant tumors]. Pathologe (2010) 1.07
A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F. Oncogene (1998) 1.07
[Organ-preserving therapy in invasive bladder carcinoma]. Dtsch Med Wochenschr (1992) 1.06